Adimuplan 25 mg filmom obložene tablete
| Name | Adimuplan 25 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-169642435 |
| Active Substance | sitagliptinklorid hidrat |
| Composition | jedna filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 25 mg sitagliptina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Lendava, Slovenija Lek Pharmaceuticals d.d., Ljubljana, Slovenija Lek S.A., Strykow, Poljska |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 04.03.2021 |
| MA Period of Validity | 04.03.2026 |
| Classification Number | UP/I-530-09/19-01/154 |
| Registration Number | 381-12-01/70-21-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BH01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
